Cladribine (Mylinax)

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Cladribine (Mylinax)

Postby patientx » Wed Dec 03, 2008 5:36 pm

In Dignan's recent post on phase III trial end dates, he mentioned Cladribine. I talked with the nurse coordinator at the MS center near me and asked about this drug. The information I got is that that phase III trials are finishing next month (as Dignan indicated), and then they are moving into an open label extension. I got no information about the data from the trials (i.e. effectiveness).

The drug does have fast track approval from the FDA, which means that, once the drug company submits its request to the FDA, the approval process should take no longer than 6 months. So, if the data from the phase III trials looks good, the estimate on availability I got was sometime in 2009.
User avatar
patientx
Family Elder
 
Posts: 1068
Joined: Wed Sep 10, 2008 2:00 pm

Advertisement

Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service